Digital Art Therapy for Young Cancer Survivors

Description

This is a single-site, single-arm, interventional study assessing the feasibility of the ARTCan Therapy Application (App) and whether it is an acceptable means of administering art therapy to young adult cancer survivors. The ARTCan Therapy App guides participants through a 6-week digital art therapy program. Subjects will participate in weekly art therapy prompts guided by the app and will complete weekly mental health quality of life (MHQoL) surveys during the intervention. In addition, baseline and end-of-intervention patient-reported outcome measures (PROMIS-DSF8a) and an acceptability survey will be administered. The hypothesis is that digital art therapy is feasible for young adult cancer survivors with self-reported mood issues and is an acceptable means of administering art therapy in the patient population.

Conditions

Cancer, Pediatric Cancer, Pediatric Malignancies, Pediatric Sarcoma of Soft Tissue, Adolescent and Young Adult With Brain Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a single-site, single-arm, interventional study assessing the feasibility of the ARTCan Therapy Application (App) and whether it is an acceptable means of administering art therapy to young adult cancer survivors. The ARTCan Therapy App guides participants through a 6-week digital art therapy program. Subjects will participate in weekly art therapy prompts guided by the app and will complete weekly mental health quality of life (MHQoL) surveys during the intervention. In addition, baseline and end-of-intervention patient-reported outcome measures (PROMIS-DSF8a) and an acceptability survey will be administered. The hypothesis is that digital art therapy is feasible for young adult cancer survivors with self-reported mood issues and is an acceptable means of administering art therapy in the patient population.

Feasibility of a Digital Art Therapy Application Designed to Improve Quality of Life in Young Cancer Survivors

Digital Art Therapy for Young Cancer Survivors

Condition
Cancer
Intervention / Treatment

-

Contacts and Locations

Chapel Hill

Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States, 27599

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Written informed assent and parental consent obtained to participate in the study and HIPAA authorization for release of personal health information.
  • * Subject is willing and able to comply with study procedures based on the judgment of the investigator.
  • * Age 18-25 years at the time of consent.
  • * Childhood cancer survivor, defined as having cancer between birth 17 years of age and who has completed cancer treatment.
  • * Reliable internet connection and access to a computer, smartphone, or iPad to support application and virtual study visits.
  • * Answers "yes" to the question "Do you experience mood issues (yes or no)?".
  • * All subjects meeting any of the exclusion criteria at baseline will be excluded from study participation.
  • * Patients who lack interest in art. Screening question: Are you open to making art on a scale from 1-5 (1 being not at all, and 5 being very much; must score 3 or higher).
  • * Subjects who lack basic technology skills (Screening question: On a scale of 1-5 (1 being uncomfortable, and 5 being very comfortable), how would you rate your comfort using websites. Must score 3 or higher).
  • * Subjects unable to provide consent.
  • * Other conditions or factors which in the opinion of the Pl would not make the patient a good candidate for the study.

Ages Eligible for Study

18 Years to 25 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

UNC Lineberger Comprehensive Cancer Center,

Soma Sengupta, MD, PRINCIPAL_INVESTIGATOR, UNC Lineberger Comprehensive Cancer Center

Study Record Dates

2027-04